MEMBER LOG-IN

LOGIN HELP

LogIn Help

SIGN UP

CLICK TO CREATE AN ACCOUNT
JOIN US or FOLLOW US HERE go to linkedIn go to twitter

New Account Registration

Yes No

Please sign me up for these other regions too:

Boston BioBreak
Philly BioBreak
New Jersey BioBreak
JPMorgan BioBreak
Europe BioBreak
All Regions
Yes No

Refer a Friend

Reset Password

JPMorgan BioBreak – Events Archive

Please see below for attendees and images from this event.

JPMorgan JPMorgan BioBreak Networking Happy Hour - January 8, 2017 January 8, 2017 6:00-8:00 pm

Co-Hosts for this event

Name Company
(No co-hosts found)

Attendees at this event

Geoff Meyerson Locust Walk
Mahmoud Mahmoudian Purdue Pharma
Jamil Beg 5AM Ventures
Scott Shandler Longevity Biotech
Mark Bausinger Neuronetics
Kristen Slaoui GlaxoSmithKline
David Brand Tarsa Therapeutics
Shawn Bridy Bridy Advisors
Warren Cooper HealthCare Royalty Partners
Rajeev Dadoo SR One
Keith Goldan Fibrocell
Deborah Harland SR One
Russel Kaufman Pappas-Capital
Peter Lanciano Periphagen Inc.
Jay Mohr Dirigo Therapeutics
Richard Morris Vitae Pharmaceuticals
Michael Palladinetti BMS
Rifat Pamukcu Midway Pharmaceuticals
Dale Pfost Advent Ventures
Kevin Taylor Kerberos BioPharma
Karen Narolewski Engel SR One
Marie Lindner Novartis
Brian McVeigh SG3 Ventures, LLC
Charles Liu AstraZeneca
Matt Handel Recensa Therapeutics
Sarabjit Ashta Prev: Dr. Reddy's Labs
Jordan Leef Pyramid Biosciences Inc
Joan Lau Militia Hill Ventures
Rachel Cervantes University City Science Center
Ros Deegan Self
Lalo Flores Novira Therapeutics
Andrew Powell Collagenex
Nate Massari AmerisourceBergen
Martin Lehr Context Therapeutics
Scott Megaffin Churchill Pharmaceuticals
Michael King PDS Biotechnology
Terence Porter Takeda
Steve Bryant Genmab
Morgan Conn CallisBio
John Peck Mesa Therapeutics
George Elston Juniper Pharmaceuticals
Tony Meehan VenatoRx Pharmaceuticals, Inc.
Donald Fishbein Evolve Therapeutics
Vikram Seoni TLC Therapeutics
Sadhana Chitale NYU
Daniel Kennedy GlaxoSmithKline
Imran Eba Action Potential Venture Capital
Sarah Frew Go Far Advisors
Peter Garabedian Pfizer
Ira Wallace Keiretsu Forum
Keith Marmer SG3 Ventures
Jeff Behrens Siamab Therapeutics
Ted Hibben Catabasis Pharmaceuticals
Christopher Schaber Soligenix
Brian Gallagher SR One
Greg Miller Visterra
Jason Walsh Provenance Biopharmaceuticals
Cameron Durrant Taran
Brad Prosek All Terrain Partners
Rick Jones Broadview Ventures
Tom Needham C4 Therapeutics
Christopher Otey Alexandria Real Estate/Alexandria Venture Investments
Paul Conrad Shire
Douglas MacDougall MacDougall Biomedical Communications
Ryan Brady Evotec
Bonnie Fendrock Cyta Therapeutics
Brad Carver SynDevRx
Phil McGurk Pfizer
Bob Silverman Roche
William Kuziel Daiichi Sankyo
Joyce Lonergan Mellitus
Derek Brand Quicksilver Biosystems
Jonathan Behr JDRF T1D Fund
Michal Preminger Harvard University
Bibhash Mukhopadhyay New Enterprise Associates
Kathryn Gregory Shire Pharmaceuticals
Dora Mitchell Penn Center for Innovation
Heather Rose Thomas Jefferson University
PJ Anand Alcyone Lifesciences
Lillian Chiang FORGE Life Science
Michael Bailey Aveo Oncology
Leslie Williams ImmusanT
Eric Olson Shire
Susan Russell GlaxoSmithKline
Caleb Winder Excel Venture
Nancy Wetherbee Tufts Medical Center
Deborah Palestrant Editas Medicine
Steven Tregay FORMA Therapeutics
Avi Spier Novartis
Arthur Hiller Antyllus Therapeutics
Oren Gilad Atrin Pharmaceuticals
Jim Weissman Dicerna
Anjan Aralihalli Glypharma
Abram Goldfinger New York University
Reda Ayache Shionogi Pharmaceutical
Harish Krishnaswamy Domain Associates
Thomas McMurry Teserx
Richard Kollender Quaker Partners
Guy Fish Fletcher Spaght
Rakhshita Dhar MassBio
Albert Robichaud Sage Therapeutics
Rob Sterling Ichor Therapeutics
Marc Hixson Coeus Group
Derek Lee Athyrium Capital
Paul Barone Inspirion Pharmaceuticals
Nicholas Spring Reliefband Medical Technologies
Cat Oyler Johnson & Johnson
Martin Phillips Tarnhelm Therapeutics
Tania Dimitrova Pfizer
Nick DAleandro Janssen
Douglas Fisher InterWest Partners
Christopher de Souza Broadview Ventures
Chris Flores Janssen
Andy Meyerson Locust Walk
Stephanie Stehman Osage University Partners
Kuldeep Neote J&J Innovation Center-Boston
Jens Eckstein SR One
Michael Boretti Epizyme
Dennis Goldberg Benu BioPharma, Inc.
Francisco Leon JNJ
Kumar Bhargava Merck
Jane Hollingsworth Militia Hill Ventures
Hugo Beekman Omega Funds
Sundeep Dugar Sphaera Pharma
Kees Been Lysosomal Therapeutics
Minji Kim Curis
Elizabeth Reczek SeqLL, LLC
John Tagliamonte WntRx
Joseph Zack Excalivir Diagnostics
Ramani Varanasi Checkmate Pharmaceuticals
John Delyani Merck
Tariq Kassum Atlas Venture
Gwen Melincoff Gemini Advisors LLC
Rick Pierce Articulate Labs
Neil Swami MVM Life Sciences Partners
Ross Leimberg AbbVie Ventures
Andrea Gerken H3 Biomedicine
Martin Heidecker Boehringer Ingelheim Venture Fund
Nick DeLong Locust Walk
Maurice T. Hampton Telesis Therapeutics, LLC
Peter Loftus The Wall Street Journal
Nathan Tinker NewYorkBIO
Tanja-Stephanie Weber Agios
James Shanahan SynDevRx, Inc.
Christopher White Sofregen Medical
Alexander Pickett Mediqventures, Ltd.
Iya Khalil GNS Healthcare
Josh Hamermesh Locust Walk
Judith Kelleher-Andersson Neuronascent
Cathy Sohn Jazz Pharmaceuticals
James Gorman Startup Mode
Bernard Rudnick Atrin Pharma
Andras Forgacs Modern Meadow
guy macdonald tetraphase
Wendy Liu Pfizer
Adele Gulfo Mylan
Cyndi Green Pfizer
Peter Leonardi OmniCyte
Hsiou-Chi Liou ImmuneTarget
Robert Spiegel Warburg Pincus
Allan Goldberg Avacyn Pharmaceuticals
Nadim Shohdy NYU
Peter Faroni Visium Asset Management
Sapan Shah ARMGO Pharma
Alan Roemer Roivant Sciences
Laura Strong Quintessence Biosciences
Joseph Sum EcoR1 Capital
David Sans Mount Sinai
Jerome Jabbour Matinas BioPharma
Bruce Goldsmith Lycera
Tom Hallam Leading BioSciences
Kyle Kuhn Acorda Therapeutics
James Leslie Celmatix
Dallin Anderson Tolero Pharmaceuticals
Sanjeev Munshi Merck
Melissa Pearlman Balfour LLC
Mona Ashiya OrbiMed
Yulii Bogatyrenko ATEM Capital
Alfonso Chang Relativity Healthcare Partners
Marc Pentopoulos Symmetry
Samuel Helfaer Athyrium
Tom Fitzgerald Velico Medical, Inc.
Lizabeth Leveille Merck
Carol Greve-Philips Spark Therapeutics
Sam Hall Apple Tree Partners
Eric Nelson Fannin Innovation Studio
Bill Fair New York Genome Center
Ailis Tweed-Kent Cocoon Biotech
Paul Bolno WaVe Life Sciences
Walter Olesiak Remiges Ventures
Bernard Davitian Sanofi
Scott Morenstein CAM Capital
Adam Rosenthal True North Therapeutics
Brian Rosenberger Cipher Pharmaceuticals
Maude Tessier Merck
Amanda Cashin Illumina
Melissa Klug AMAG Pharma
Michael Shih Consulting
Stefan Vitorovic Third Rock Ventures
Jennifer Laux Inovio Pharmaceuticals
Lee Kalowski Tokai Pharmaceuticals
Stephen Potter AGTC
April Effort Allena Pharmaceuticals
Carol Ashe New York Genome Center
Demetrios Kydonieus R-Pharm US
Michael Batten JDRF
Edward Hamati BioGenerator
Timothy Sullivan AJU IB Investment
Christopher Earl Merck Global Health Innovation Fund
Eric Zimmerman Excel Venture Management
david hirsch longitude capital
Imran Babar Venture Capital
Matt Rieke Johnson & Johnson
Patrick Tricoli NANOBIOTIX US
Sourav Sinha Oncolinx
Christo Shalish Warp Drive Bio
Jay Knowles Partners Innovation Fund
Chris Primiano Karyopharm Therapeutics
Howard Weisman Seventh Sense Biosystems, Inc.
Vicki Morgan viDA Therapeutics
Todd Davis HealthCare Royalty Mgmt
Skip Irving Stemnion
Andrew meadow Conceivex, Inc.
Ivana Magovcevic-Liebisch Teva
Mathias Woker Synovo GmbH (USA)
Kathie Jordan Drexel University
Brandi Simpson Navigen
Ken Kovan Phelix Therapeutics LLC
Gregory Mario TAXIS Pharmaceuticals, Inc.
John Krayacich Novartis
Isaac Treitel MedPro Investors
Kevin Chu F-Prime Capital Partners
Fumitaka Mori Remiges Ventures
Gary Phillips Mallinckrodt
Manos Perros Entasis Therapeutics
Tarik Soliman Extend Biosciences
Anna Christo MassBio
Duncan Hamish Wright Merck/MSD
Thomas Martz Goldfinch Bio
Helen Boudreau FORMA Therapeutics
Guillermo Rubio AMAG Pharmaceuticals
Bryan Stuart Kastle Therapeutics
Mary Thistle Dimension Therapeutic
Jennifer Wheler Novartis
Phillip Samayoa Atlas Ventures
Henry Rath Seres Therapeutics
Remis Bistras ProFarma
Jonathan Mandelbaum Accelerator Corporation
Christopher Scannell Akrivis
Frank Walsh Ossianix
James Glasheen Technology Partners
Nolan Sigal Tunitas Therapeutics, Inc.
Rathin Das Synergys Biotherapeutics
Constantine Theodoropulos GO Therapeutics
Paul Lammers Mirna Therapeutics
Jonathan Kaufman Lipella Pharmaceuticals
Stephen Simes RestorGenex
Stephen Curtis Eli Lilly and Company
Jonathan Root US Venture Partners
Tito Serafini Atreca
Will Robberts TesoRx Pharma
Michael Todd Urotech Surgical
Ilan Zipkin Takeda Ventures
Rishi Gupta OrbiMed
Christine Brennan MRL Ventures Fund
Edgardo Baracchini Xencor
Ken Kengatharan Armetheon
Janette Dixon Innate Immunotherapeutics Limited
Jane Dancer F-star
Simon Wilkinson Innate Immunotherapeutics Ltd
John Haurum F-star
Tina Garyantes Chromocell
Alok Ghosh NAYAderm
Sheila DeWitt DeuteRx
Timothy Trost Chimerix
Don Zinn Microbion
Nicholas Sarlis Sellas Life Sciences Group
Anh Hoang Sofregen Medical
Jeffrey Wade Lexicon Pharmaceuticals
Patrick O'Donnell ProteoThera
Wen Luo Denovo Biopharma
Gary Novack PharmaLogic Development
Gladys Nunez Amgen
Michael Poisel University of Pennsylvania
ronald martell Achieve Life Sciences
Vishal Kapoor Ophthotech
Crystal Icenhour Aperiomics
Ted Marple Acworth Pharmaceuticals, Inc.
Joseph Siletto Vivo Capital
Tanya Shnaydman Iconic Therapeutics
Debbie Hart BioNJ
Anne Altmeyer Baxalta
Michael Wiley Foundation Venture Capital Group
Gary Lee Amicus Therapeutics
Joe Whalen Horizon Pharma
Darren Braccia Lysosomal Therapeutics
Jared Kaleck Klein Hersh International
Anthony Recupero Adare Pharmaceuticals
Anne Marie Robertson Helsinn
Ari Brettman Clarus Ventures
Mark Tepper Corbus Pharmaceuticals
Glenn Larsen Aquinnah Pharmaceuticals
Linda Brown BioNJ
Naoya Sato MP Healthcare Venture Management
Ray Krauss Camras Vision
Raymond Houck Meraki Pharmaceuticals
Oren Isacoff Longitude Capital
Carlo Rizzuto Versant Ventures
John Brooks Arete Worldwide
Jim Golubieski NJ Health Foundation
ole mikkelsen Accuray Incorporated
Abhishek Mukhopadhyay Dr. Reddys Laboratories Inc
Lisa Ricciardi Foundation Medicine
John Freshley ONL Therapeutics
Ross Youngs Biosortia Pharmaceuticals
brent vaughan Cognoa, Inc
Michael Garrett EnBiotix
Robert Beardsley Galera Therapeutics
Anil Goyal MimiVax, LLC
Martin Cearnal CumberlandPharmaceuticals
Adam Bruce TikoMed
Leo Ehrlich Cellceutix
Meredith Fisher Partners Innovation Fund
Kyle Gano neurocrine biosciences
Peter Heinecke Aimmune Therapeutics
Thomas Dyrberg Novo a/s
Koji Naito Mitsubishi Tanabe Pharma Corporation
Janice Bourque Hercules Technology Growth Capital
Michael Nall Biocept
Patrick Cheng Mount Sinai Innovation Partners
Bradley Campbell Amicus Therapeutics
Takuro Wakabayashi ASTEC
Thierry Abribat Alize Pharma
Steve Engen Locust Walk
Michelle Fang Athyrium Capital
Allen Ruszkowski CVAC Systems
Bobby Sandage Euclises Pharmaceuticals
Fanni Fan Rosemark Capital
Gaurab Sengupta Dr. Reddy's Laboratories
Hironori Hozoji TTM Advisors, LLC
Jeff Peterson Target Discovery & Veritomyx
John Gregg Balinbac Therapeutics
Michael Klein Inflection Point
Philippe Douville Milestone Pharmaceuticals
David Larwood Valley Fever Solutions
Bruce Beutel SQZ Biotech
Eric Stone Velano Vascular
Jie Liu Torreya Partners
Richard Sachse AEZS
TR Thirucote TesoRx Pharma
Ben Palleiko Cielo Therapeutics
Cayce Denton TPG
Tom Kassberg Ultragenyx Pharmaceutical
Ming Fang Redmile
Bryant Fong Biomark Capital
Yael Weiss Ultragenyx Pharmaceutical
Peter McWilliams Sanderling Ventures
Jai Wall Sebela
Ian Li 1315 Capital
Mark Reynolds GeoVax
Christian Kopfli Chromocell
Daniel Wee T3S Technologies
Scott Platshon EcoR1 Capital
Mark Diamond Antisense Therapeutics
Beth Klein DuraThera
Mirza Cifric Veritas Genetics
Richard Pines Athyrium Capital
Michael Haller Peloton Therapeutics
Monica Beam Alexandria Venture Investments
John Edwards F-star
Brad Morgan POC Medical Systems
Nick Conley EpiBiome
Lu Alleruzzo Immunophotonics
Michael Webb Tyrogenex
Ed Addison Cloud Pharmaceuticals
Jack Pasini Oligomerix
James Moe Oligomerix
Joshua Sherman Apple Tree Partners
Mary Ann Gray Gray Strategic Advisors
Anupam Agarwal Gilead Sciences
Dennis He Silicon Valley Bank
Bernhard Kappe Pathfinder Software
Amanda Kay Synlogic
George NG Sorrento Therapeutics
Mary Page Platerink First Aid Beverages
Michael Paul Lineagen
Danguole Altman Vapogenix
Michael Detke Embera NeuroTherapeutics
DA Gros Neurocrine Biosciences
Sassan Rafizadeh AccenGen
Kollol Pal Pyramid Biosciences
Nail Edikhanov Klyss Biotech
Steven Bloom Verastem
Sara Nunez-Garcia Sofinnova Partners
Ashleigh Palmer Celimmune
Brian Kwok Fusion Genomics
Laurie Actman PCI
Roz Sweeney PDL Biopharma
Oliver Summerfield Inventages Venture Capital
Pete Garcia PDL BioPharma
Karen Boezi Broadway Angels
Ling Wong SLV
Sacha Mann Inventages
Douglas Kawahara Elex Biotech
Deborah Chen D3 Drug Discovery and Development
Mario Alberto Accardi Fort Rock Capital
Katie Ellias Sofinnova partners
Gail Naughton Histogen
Rhonda Bracey Channel Medsystems
Gregory Hanson MabVax Therapeutics
Robin Isaacs Entasis Therapeutics
Randy Rivera GC Finance
Shahzad Malik Advent Life Sciences
Shaker Reddy Metaclipse Therapeutics
Jonathan Kabakoff Alexandria Venture Investments
Milenko Cicmil Merck
Zack Scott Leerink Revelation Partners
Carter Keller GigaGen
Elizabeth Aylward Seattle Children's Research Insitute
Michael Tippie TomegaVax, Inc.
Ping Guo The puguang investment holding group
Rakesh Marwah Palo Alto Investors
Timothy Considine Recursion Pharmaceuticals
Christopher Gibson Recursion Pharmaceuticals
Sara Radcliffe California Life Sciences Association
Ruchita Sinha Sanofi Ventures
Robert Little Denovobiopharma
Yeda Mancini FordPharma
Randy Preston Esculon Inc.
Bin Sun Everbright
Bruce Phelps Mellitus
Jayson Punwani Pappas Ventures
Scott Weiner Pappas Ventures
Eric Leire DanDrit Biotech
Eric Waehner Takeda
Renuka Babu Dots
Austin Walker Innovein
Stephen Nagler MedPro Investors
Mervyn Maze NeuroproteXeon
John Taylor Spyryx Biosciences
Michael Roy Mallinckrodt
Pete Wolf Nabriva Therapeutics
Josh Schafer mallinckrodt
Sam tetlow EpiCypher
Katie Gordon Brown University
Patrice Milos Medley Genomics
Dennis McNamara Path BioAnalytics
David Soergel Trevena
Ivan Joseph Hsiri Therapeutics
Francine Del Ricci Teva Pharmaceutical
Brendan Luu EMD Serono Inc.
Matthew Hawryluk Gritstone Oncology
Donald Corcoran Cyteir Therapeutics, Inc.
Kevin Mills Cyteir Therapeutics, Inc
Annie Mitsak Omega Funds
Edwin Holland Cenoxsys, LLC
Jeni Lee Novo Ventures
Chris Mason AVROBIO
Cavan Redmond Zarsy, LLC
Kate Rumrill NeoSync, Inc.
Siddarth Subramony H.I.G. Capital
Aaron Nelson dRx Capital
Jorge Ramirez H.I.G. Capital
Sanjay Mistry Janssen Pharmaceuticals
Joseph Vacca Highline Therapeutics
Benjamin Lewis The One Health Company
Alex Howarth Lycera
John M Sorvillo ReForm Biologics
Elizabeth Wagner Constant Pharmaceuticals
Julie DeSander Agenus
Stefano Gulla Abcuro
Barbara Sosnowski Pfizer
Jonathan Freve Spring Bank Pharmaceuticals, Inc.
Maria Zlyhastseva BioBreak
David Raiser Aldatu Biosciences
Jim Ellis GSK
Thomas Bliss Genisphere
Armin Rump Otsuka Pharmaceutical
Susan Dillon Janssen R&D
Rich Daly Neuralstem, Inc.
Ben Cowen ImmunoMet Therapeutics
Peter Harwin Fairmount Funds
Tomas Kiselak Fairmount Funds Management LLC
Scott Applebaum Independent
Steven Gelone Nabriva Therapeutics
Neil Lineberry Takeda Pharmaceuticals
Matthew Gantz Sobi
Chiraag Patel chimeron bio
Saar Gill CARMA Therapeutics
Alan Ginsberg Shire
Paul Blake Albury Biopharm
Nagesh Mahanthappa Scholar Rock, Inc.
Cassie Tran Children's Hospital of Philadelphia
Nimesh Shah Fractyl Labs
Paul Stead Inovio Pharmaceuticals
Jonathan Heller Pfizer, Inc.
Ram Aiyar Corvidia Therapeutics
Carolyn Green Pfizer
Morris Birnbaum Pfizer
Stuart Blitz 7SBio
Stefano Fratarcangeli Self
Steve Carchedi Apexian Pharmaceuticals
Charles Link NewLink Genetics
Brian Wiley NewLink Genetics
Nicholas Vahanian NewLink Genetics
John Henneman III NewLink Genetics
Frederic Ors Immunovaccine Inc.
David Matly Chrono Therapeutics
Thomas Mathers CoLucid Pharmaceuticals
Jocelyn Trokenheim Takeda Pharmaceuticals
Rashida Karmali Tactical Therapeutics, Inc
christophe degois Aimmune Therapeutics
James Feeney ApoConsult LLC
Jennifer McGovern Ironwood Pharmaceuticals
Michael Handley CHD Bioscience, inc.
Warren Czerniak Gedeon Richter USA
David Coats Correlation Ventures
Michael McCully Locust Walk
isabelle trempe Paladin Labs
Stewart Davis Locust Walk Partners
Shigeru Yasue Mitsubishi UFJ Capital Co.,Ltd.
James Cornicelli UCB BioPharma
Virginie ALLIX VIRBAC
Akira Kato Shionogi & Co.,Ltd.
Perry Nisen Sanford Burnham Prebys Medical
Magnus Precht SinSa Labs Inc.
Meg Helms Morgan Wallace Associates
Tom Graney Ironwood Pharmaceuticals
Bryan Lord Orthopedic Venture Partners
Jeff Jonas Sage Therapeutics
Jernej Godec Apple Tree Partners
Soon Hyouk Lee Acorda Therapeutics
Dean Miller PACT
Christopher Holterhoff Amicus Therapeutics
William Gerhart Patara Pharma
Gong Chen NeuExcell Therapeutics Inc
Hiroshi Kawai Mitsubishi Tanabe Pharma Holdings America Inc.,
Mike Quinn Innate Immunotherapeutics Ltd
Josh Mandel-Brehm Biogen
Ricky Sun Bain Capital
Robert Kieval CVRx, Inc.
Monique Da Silva Spark Therapeutics
Gurpreet Ratra Spark Tx
John Holaday ExoCyte Therapeutics
Barry Frankel Sedor Pharmaceuticals
Daniel Wattier ImStar Therapeutics Inc.
Vincent Aurentz Arena Pharmaceuticals
Court Turner Avalon Ventures
Lisa McKerracher BioAxone Biosciences Inc.
Cathy He Highlight Capital
Peter Haberz MEI Pharma
Victoria Cameron Hercules Capital
Matthew Hawryluk Gritstone Oncology
William Korinek Astrocyte Pharmaceuticals
Michihito Onishi Locust Walk
Joseph Plevelich FEMME PHARMA
Jock Holliman LipimetiX Development
Kenneth Kashkin Chromocell Corporation
Shobha Parthasarathi Harrington Discovery Institute
Steven Gullans Excel Venture Management
Nick Mordwinkin Ultragenyx Pharmaceutical
James Manuso RespireRx Pharmaceuticals Inc.
MELDA UZBIL Variant Pharmaceuticals
Michael Dudley TransCode Therapeutics, Inc.
Alan Ezrin NX Development Corp
Pablo Legorreta Royalty Pharma
Arthur Klausner Gem Pharmaceuticals
Michael Davidson Corvidia Therapeutics, Inc
Daniel Paterson Verastem
Matt Devalaraja Corvidia Therapeutics, Inc
Rahul Kakkar Corvidia Therapeutics, Inc
Joe Cunningham Santé Ventures
Dennis Purcell Aisling Capital LLC
Richard Hoyt Mallinckrodt
Wendy Nelson Transcode Therapeutics
Kaveh Milaninia Multerra Bio
John Warmath Wright Medical
Edward Kliphuis Merck Ventures
Dajun Yang Ascentage Pharma
Clark Sullivan Cox Biosciences
John Hamill NephroGenex, Inc
Takashi Noaki Santen Inc
Jonathan Silverstein OrbiMed
Tim Hauch Respicardia, Inc.
Charlotte Hubbert Bill & Melinda Gates Foundation
William Williams BriaCell Therapeutics Corp.
Saeid Babaei BriaCell Therapeutics Corp.
karen larochelle PsiOxus Therapeutics
Mukilan Mohan INanoBio Inc.
Sajai Singh J. Sagar Associates
Bharath Takulapalli INanoBio Inc
Michael Nelson Intrommune Therapeutics
Chris Cain Apple Tree Partners
Erick Berglund Intrommune Therapeutics
Anthony Robinson Intrommune Therapeutics
rivka Kreitman Teva
Wael Fayad Enumeral
Allison Fritts Janssen
Eric Risser MacroGenics Inc.
Kazuhiro Umeda M3i, Inc.
Eckhard Niemeier Pieris Pharmaceuticals GmbH
david krisky Periphagen
John Oksinski NeuClone
Russell Howard NeuClone
Noelle Sunstrom NeuClone
Tomas Landh Novo Nordisk
Daniel Seto SternAegis Ventures
Shawn Marcell ReadCoor
Rachael Hagan Coulter Fund
Rebecca Levit CorAmi
Angela Huang Tempo Bioscience
Jack Leonard Acworth Pharmaceuticals, Inc
Anders Wiklund Wiklund International
Ross Breckenridge Silver Creek Pharmaceuticals
Douglas Fambrough Dicerna Pharmaceuticals
Jerry Casey Mellitus, LLC
Scott Jenkins AlleCures
Daniel Katzman Unleash Immuno Oncolytics
Sanjeev Redkar CBT Pharmaceuticals Inc.
Brad Tritle vitaphone USA
George Maynard Axerion Therapeutics, Inc.
Jeff Stevens Puretech Health
Christopher Belnap Resilient Biotics, Inc
Erik Gentalen Intabio
Vishal Kapoor Bastion Biologics
William Altman CorInnova, Inc.
Jenny Liu MIT Alumni Angels
Kenneth Kashkin Chromocell
John DeYoung Pfizer Inc
Edoardo Negroni Inorgen Ltd
Lisa Placanica Mount SInai Innovation Partners
Anne Vallerga AlleCures Inc
Stephen Lensky EpimAb Biotherapeutics
Avina Sun OceanIQ Capital
Robb Lawrence TLC Therapeutics
Madhavan Nallani ACM Biolabs
Daniella Kranjac Dynamk Capital
Vistasp Sethna Serum Institute of India
Brendan Gallagher Sentieon Inc
Xiurong Ye Rainbow Medical Ltd
Elliot Bland Stabilitech Ltd
Ulrich Rodeck Akriveia Therapeutics
Loraine Upham CureDM
Brad Theien Filament BioSolutions
Mark Lee Genentech
Natalie McCan ChannelPharma
Richard Strakosch Genentech
Ruby Holder Roivant Sciences
Tushar Karkhanis Genentech
Sam Assmann California Life Sciences Association
Lucinda Quan Merck
Tom Cirrito Filament BioSolutions
viktor Goldin VENTREX INC
Kristina Rinker KRS BioPharma
Hans Preusting Crossbeta Biosciences
Jeff Drew Stabilitech Ltd
ILAN HADAR FOAMIX PHARMACEUTICALS LTD
Guus Scheefhals Crossbeta Biosciences
Alberto Santagostino McKinsey & Company
Evelina Georgieva PRYV SA
Marshall Hayward Jupiter Orphan Therapeutics
Lupe Cipres Trillium Medical Ventures
Robin Garner HighCape Partners
Kia Motesharei EMD Serono
Hassan Alaoui AtlasMedx, Inc
Matthew Schiller EMD Serono
Robert Hoffman innovus
Tom Witt Avanir Pharmaceuticals
Jennifer North Regeneron Pharmaceuticals
Vikas Sharma MacroGenics
Joel Berger Takeda Pharmaceuticals
Neil Exter Third Rock Ventures
JeShaune Jackson EpiBiome Inc.
Michelle Linn Agenus
David Zarling Colby Pharmaceutical Company
Ely Benaim Rexahn Pharmaceuticals
Brandon Lewis Alsonex Pty Ltd
Michael Van Zandt ARC Institution
Michelle Wu Wuxi Healthcare Venture
Larry Cai Qilu
Christopher Hanson Grant Park Ventures
Kousuke Nakata Kissei Pharmaceutical Co., Ltd.
Katsuyoshi Akiyama Kissei Pharmaceutical Co., Ltd.
Sandeep Bhadra Menlo Ventures
Ashley Nagle Domain Therapeutics
Anton Giorgio Failla Chiesi Farmaceutici Spa
Bettina Haedrich QIAGEN
Hunt Henrie Locust Walk
Doug Martin ProclaRx
Matthew De Silva Notable Labs
Christopher Shepard SBE
Jeanne Farrell Mount Sinai Innovation Partners
Francisco Salva Acerta Pharma
shubhra jain wharton
JH Schroeder Neuro Kinetics, Inc.
Jonas Ekblom Edge of the World Strategies Corporation
Jeremy Sonnier TriNet
Lori Hu Vertex Healthcare
Masaaki Kotaki Daiichi Sankyo
Nate Kurtis The Broad Institute
Fauad Hasan Bonti
Sukaina Alarakhia Moore Venture Partners
Jesper Lykkesfeldt Genmab A/S
Simon Jones Regenacy Pharmaceuticals LLC
Thomas Farb-Horch Thrive Bioscience, Inc.
Susan Washer AGTC
Andrew Taylor Angel Medical
Raj Mohanty FemtoDx
Paul Weinberger Diasolve
Patrick Shea Egalet US Inc.

Become a Supporter

For more information about sponsorship, please email us at sponsorship@biobreak.org.

Web design: GillFishmanDesign.com